CARBOGEN AMCIS, a Dishman Carbogen Amcis Group company, is an integrated drug substance to drug product CDMO headquartered in Switzerland with nine facilities across Europe and Asia. The company provides a portfolio of APIs, as well as custom chemical expertise, analytical services, process development and scale-up, and GMP commercial manufacturing. Their chemical proficiency includes alkylations, peptide coupling, esterification, heterocycle synthesis, nucleotides, and other techniques for use with different potencies of intermediates and APIs.
